Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eyepoint Pharmaceuticals Inc
(NQ:
EYPT
)
9.190
+0.190 (+2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eyepoint Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
August 13, 2024
Via
Benzinga
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 12, 2024
Via
Benzinga
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
July 12, 2024
Via
Benzinga
Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings)
May 07, 2024
Via
Benzinga
Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know
March 08, 2024
Via
Benzinga
A Preview Of EyePoint Pharmaceuticals's Earnings
March 06, 2024
Via
Benzinga
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
May 13, 2024
Via
Benzinga
EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 08, 2024
EYPT stock results show that EyePoint Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 08, 2024
Via
Benzinga
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
May 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Unveiling 7 Analyst Insights On EyePoint Pharmaceuticals
January 22, 2024
Via
Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
May 06, 2024
Via
Benzinga
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
May 06, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 06, 2024
Via
Benzinga
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
May 06, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
May 06, 2024
EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via
Benzinga
Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
April 23, 2024
Via
Benzinga
EYPT Stock Earnings: EyePoint Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
March 07, 2024
EYPT stock results show that EyePoint Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
March 04, 2024
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The 3 Most Promising Stocks to Invest in Before They Take Off
February 17, 2024
Sponsored by potential FED interest rate cuts, these are the top stocks to invest in before they take off later this year.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
February 03, 2024
From
EyePoint Pharmaceuticals, Inc.
Via
GlobeNewswire
$30M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
January 12, 2024
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
Via
Benzinga
Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December
December 19, 2023
Amidst fanfare for Nasdaq 100, U.S. small-cap stocks rally, with Russell 2000 index reaching levels not seen since Aug. 2022, 80% of stocks trading above 50-day MA, outperforming large caps &...
Via
Benzinga
Topics
ETFs
$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
December 13, 2023
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
December 08, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Camtek Ltd.
Via
Benzinga
Insiders Buying Dave And 2 Other Stocks
December 07, 2023
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.